GLP-1 Receptor Agonists and Duplicate Therapy Risks Taking multiple GLP-1 receptor agonists simultaneouslysuch as semaglutide and dulaglutide, or semaglutide and liraglutidecreates redundant signals that increase nausea, vomiting, and dehydration risk
Helps you stay fuller for longer
Dose timing, dietary tweaks, and supportive meds can help
You might be a good fit if: You have a BMI of 30 or higher (obesity) You have a BMI of 27 or higher plus at least one weight-related health condition like high blood pressure, high cholesterol, or type 2 diabetes You've tried diet and exercise but still struggle with significant weight issues You don't have a personal or family history of medullary thyroid cancer or Multiple Endocrine Neoplasia syndrome type 2 But there are some subtle differences in who might do better with one medication versus the other
This guide breaks down every question people are asking about microdosing, from the exact unit-by-unit chart to the weekly schedule most patients follow, the real science on inflammation, and the honest part most articles skip: when microdosing simply isnt enough, and what to do next
